	US 12,331,060 B2
	N-substituted tetrahydrothienopyridine derivatives and uses thereof
Cyrille Kounde, London (GB); Wei Lin Sandra Sim, Singapore (SG); Oliver Simon, Singapore (SG); Gang Quan Wang, Singapore (SG); Hui Quan Yeo, Singapore (SG); Bryan Ks Yeung, Seoul (KR); Fumiaki Yokokawa, Dublin, CA (US); and Bin Zou, Singapore (SG)
Assigned to NOVARTIS AG, Basel (CH)
Filed by NOVARTIS AG, Basel (CH)
Filed on May 7, 2024, as Appl. No. 18/657,123.
Application 18/657,123 is a continuation of application No. 17/253,755, granted, now 12,012,417, previously published as PCT/IB2019/055121, filed on Jun. 18, 2019.
Claims priority of provisional application 62/687,068, filed on Jun. 19, 2018.
Prior Publication US 2024/0352030 A1, Oct. 24, 2024
Int. Cl. C07D 495/04 (2006.01); A61K 31/4365 (2006.01); A61K 45/06 (2006.01); A61K 47/06 (2006.01); A61P 31/12 (2006.01)

CPC C07D 495/04 (2013.01) [A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61P 31/12 (2018.01)]

2 Claims

1. A compound of formula (I), or a pharmaceutically acceptable salt thereof, selected from: